tiprankstipranks
Advertisement
Advertisement

ARMP Stock Latest News

Armata Shareholders Approve Directors, Executive Pay and Auditor
Company AnnouncementsArmata Shareholders Approve Directors, Executive Pay and Auditor
1d ago
8K
ARMP
Analyst Reiterates Buy on Armata, Maintaining $20 Price Target Ahead of Pivotal Phase 3 AP-SA02 Trial
PremiumRatings
Analyst Reiterates Buy on Armata, Maintaining $20 Price Target Ahead of Pivotal Phase 3 AP-SA02 Trial
21d ago
ARMP
Armata Secures New Loan Amid Wider Quarterly Loss
PremiumCompany Announcements
Armata Secures New Loan Amid Wider Quarterly Loss
1M ago
8K
ARMP
Armata Pharmaceuticals reports Q1 EPS ($3.16) vs. (20c) last year
PremiumThe Fly
Armata Pharmaceuticals reports Q1 EPS ($3.16) vs. (20c) last year
1M ago
ARMP
Armata Pharmaceuticals secures FDA Fast Track Designation for AP-SA02
PremiumThe Fly
Armata Pharmaceuticals secures FDA Fast Track Designation for AP-SA02
1M ago
ARMP
Armata Gains FDA Fast Track for AP-SA02 Therapy
PremiumCompany AnnouncementsArmata Gains FDA Fast Track for AP-SA02 Therapy
1M ago
8K
ARMP
Armata Pharmaceuticals Adds Pfizer Executive to Board of Directors
Premium
Company Announcements
Armata Pharmaceuticals Adds Pfizer Executive to Board of Directors
2M ago
8K
ARMP
Armata Pharmaceuticals price target raised to $20 from $15 at JonesResearch
Premium
The Fly
Armata Pharmaceuticals price target raised to $20 from $15 at JonesResearch
2M ago
ARMP
Armata Pharmaceuticals Sets Timeline for 2026 Annual Meeting
PremiumCompany Announcements
Armata Pharmaceuticals Sets Timeline for 2026 Annual Meeting
3M ago
8K
ARMP
Armata Pharmaceuticals reports Q4 EPS ($3.42) vs. (23c) last year
PremiumThe Fly
Armata Pharmaceuticals reports Q4 EPS ($3.42) vs. (23c) last year
3M ago
ARMP
Armata Highlights AP-SA02 Progress Amid Earnings Release Delay
PremiumCompany Announcements
Armata Highlights AP-SA02 Progress Amid Earnings Release Delay
3M ago
8K
ARMP
Armata Pharmaceuticals delays announcement of Q4, FY25 results
PremiumThe Fly
Armata Pharmaceuticals delays announcement of Q4, FY25 results
3M ago
ARMP
ARMP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsARMP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
ARMP
Armata price target raised to $15 from $9 at H.C. Wainwright
Premium
The Fly
Armata price target raised to $15 from $9 at H.C. Wainwright
4M ago
ARMP
Armata Gains QIDP Status for AP-SA02 Bacteremia Therapy
Premium
Company Announcements
Armata Gains QIDP Status for AP-SA02 Bacteremia Therapy
4M ago
8K
ARMP
Armata Pharmaceuticals receives FDA QIDP designation for AP-SA02
PremiumThe Fly
Armata Pharmaceuticals receives FDA QIDP designation for AP-SA02
4M ago
ARMP
Armata Extends Innoviva Credit, Warrants and Voting Pact
PremiumCompany Announcements
Armata Extends Innoviva Credit, Warrants and Voting Pact
5M ago
8K
ARMP
Armata Pharmaceuticals: FDA-Endorsed Phase 3 Path and Potential QIDP Upside Support Buy Rating on AP-SA02
PremiumRatings
Armata Pharmaceuticals: FDA-Endorsed Phase 3 Path and Potential QIDP Upside Support Buy Rating on AP-SA02
5M ago
ARMP
Armata Wins FDA Support to Advance Bacteriophage to Phase 3
PremiumCompany Announcements
Armata Wins FDA Support to Advance Bacteriophage to Phase 3
5M ago
8K
ARMP
Armata Pharmaceuticals announces End-of-Phase 2 meeting with FDA
PremiumThe FlyArmata Pharmaceuticals announces End-of-Phase 2 meeting with FDA
5M ago
ARMP
Armata Pharmaceuticals initiated with a Buy at JonesResearch
Premium
The Fly
Armata Pharmaceuticals initiated with a Buy at JonesResearch
5M ago
ARMP
Armata Pharmaceuticals Enters Capital Sales Agreement
Premium
Company Announcements
Armata Pharmaceuticals Enters Capital Sales Agreement
7M ago
8K
ARMP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >